NFE2L2 and neoplasm: It has been demonstrated that the activation of the Nrf2 pathway provides a survival advantage in response to selective pressure (e.g., lack of nutrients, oxidative stress, hypoxia) during tumour development and may confer resistance to chemotherapy or radiation during tumour progression [51, 65].